THERAPEUTICS OF X-LINKED HYPOPHOSPHATEMIC RICKETS

被引：11

作者：

LATTA, K ^{[1
]}

HISANO, S ^{[1
]}

CHAN, JCM ^{[1
]}

机构：

[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,CHILDRENS MED CTR,DEPT PEDIAT,DIV NEPHROL,RICHMOND,VA 23298

来源：

PEDIATRIC NEPHROLOGY | 1993年 / 7卷 / 06期

关键词：

X-LINKED HYPOPHOSPHATEMIC RICKETS; NEPHROCALCINOSIS; HYPERCALCIURIA; PREGNANCY;

D O I：

10.1007/BF01213343

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

X-Linked hypophosphatemia, the most common form of familial rickets, is conventionally treated with 1,25-dihydroxyvitamin D-3 (5-50 ng/kg per day) plus phosphate supplementation (70-100 mg/kg per day). However, nephrocalcinosis is noted in many children treated with this therapy. Whether to treat or not and whether such treatment should be continued into adulthood or in pregnancy are unsettled questions. This article reviews these controversies and provides current recommendations.

引用

页码：744 / 748

页数：5

共 36 条

[1]

Rasmussen H., Tenenhouse H.S., Hypophosphatemias, The metabolic basis of inherited disease, pp. 2581-2604, (1989)

[2]

Bell N.H., Vitamin D-endocrine system, J Clin Invest, 76, pp. 1-6, (1985)

[3]

Glorieux F.H., Scriver C.R., Holick M.F., DeLuca H.F., X-linked hypophosphatemic rickets: inadequate therapeutic response to 1,25 dihydroxycholecalciferol, Lancet, 2, pp. 287-289, (1973)

[4]

Brickman A.S., Coburn J.W., Kurokawa K., Bethune J.E., Harrison H.E., Norman A.W., Actions of 1,25 dihydroxycholecalciferol in patients with hypophosphatemic rickets, New England Journal of Medicine, 289, pp. 495-498, (1973)

[5]

Hirschman G.H., DeLuca H.F., Chan J.C.M., Hypophosphatemic vitamin D-resistant rickets: metabolic balance studies in a child receiving 1,25-dihydroxyvitamin D3, phosphate, and ascorbic acid, Pediatrics, 61, pp. 451-457, (1978)

[6]

Chan J.C.M., Bartter F.C., Hypophosphatemic rickets: effect of 1-α-25-dihydroxyvitamin-D3 on growth and mineral metabolism, Pediatrics, 64, pp. 488-495, (1979)

[7]

Chan J.C.M., Lovinger R.D., Mamunes P., Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin D3, Pediatrics, 66, pp. 445-454, (1980)

[8]

Glorieux F.H., Marie P.J., Pettefore J.M., Delvin E.E., Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets, N Engl J Med, 303, pp. 1023-1031, (1980)

[9]

Rasmussen H., Pechet M., Anast C., Mazur A., Gertner J., Broadus A.E., Long term treatment of familial hypophosphatemic rickets with oral phosphate and 1α-hydroxyvitamin D3, J Pediatr, 99, pp. 16-25, (1981)

[10]

Lyles V.W., Harrelson J.M., Drezner M.K., The efficacy of vitamin D2 and oral phosphorus therapy in X-linked hypophosphatemic rickets and osteomalacia, J Clin Endocrinol Metab, 54, pp. 307-315, (1982)

← 1 2 3 4 →